The Sabin Vaccine Institute announced it has provided 700 of its Marburg Virus Disease (MVD) vaccine candidates (PHV01) to the Republic of Rwanda to support the ongoing disease outbreak response.
As of October 5, 2024, the initial vaccine shipment will be used in a trial targeting frontline workers in Rwanda, including healthcare professionals.
Pending a request from Rwandan officials and authorization from others, Sabin plans to supply additional vaccines.
700 Marburg Vaccine Candidates Heading to Rwanda
Nepal's Japanese Encephalitis Outbreak Claims 17 Lives
Over the past few decades, Japanese encephalitis (JE) has been a significant concern in the Federal Democratic Republic of Nepal, particularly during the annual monsoon season in the Himalayan Mountains.
According to news from The Kathmandu Post, 63 people have been infected with the mosquito-borne zoonotic viral disease since June 2024. Tragically, as of September 22, 2024, 17 people, including children, have died from JE infections this year.